Sales Staff Warning Letter


sales staff warning letter Hauptschablonenbild
Klicken Sie auf das Bild zum Vergrößern

Speichern, ausfüllen, drucken, fertig!
How to write a Sales Staff Warning Letter? Download this Sales Staff Warning Letter template now!


Verfügbare Gratis-Dateiformate:

.pdf


  • Dieses Dokument wurde von einem Professional zertifiziert
  • 100% anpassbar


  
Benutzer-Bewertung: 8

Malware- und virenfrei. Gescannt von: Norton safe website


Business Unternehmen HR Personalabteilung Sales Vertrieb Letter schreiben Drug Droge Pharmaceuticals Pharmazeutika Everything You Need To Know About A Warning Letter Alles, was Sie über einen Warnbrief wissen müssen

How to draft a Sales Staff Warning Letter? Download this Sales Staff Warning Letter template now!

We support you and your company by providing this Sales Staff Warning Letter HR template, which will help you to make a perfect one! This will save you or your HR department time, cost and efforts and help you to reach the next level of success in your work and business!

This Sales Staff Warning Letter has ways to grab your reader’s attention. It is drafted by HR professionals, intelligently structured and easy-to-navigate through. Pay close attention to the most downloaded HR templates that fit your needs.     

Download this Human Resources Sales Staff Warning Letter template now!

DEPARTMENT OF HEALTH HUMAN SERVICES Public Health Service Food and Drug Administration Silver Spring, MD 20993 TRANSMITTED BY FACSIMILE ECR Pharmaceuticals, a wholly owned subsidiary of Valeant Pharmaceuticals International Attention: J.. Michael Pearson, CEO Valeant Pharmaceuticals International 400 Somerset Corporate Center Bridgewater, NJ 08807 RE: ANDA 077273 TussiCaps® (hydrocodone polistirex and chlorpheniramine polistirex) Extended-release Capsules CII 1 MA 86 WARNING LETTER Dear Mr. Pearson: The Office of Prescription Drug Promotion (OPDP) of the U.S. Food and Drug Administration (FDA) has reviewed a professional sales aid (DTUS3B) (sales aid) for TussiCaps® (hydrocodone polistirex and chlorpheniramine polistirex) Extended-release Capsules CII (TussiCaps) submitted by ECR Pharmaceuticals under cover of Form FDA 2253.. In order to clearly identify the violative promotional piece(s) and/or activity and focus on the corrective message(s), OPDP recommends that corrective piece(s) include a description of the violative promotional pieces and/or activity, include a summary of the violative message(s), provide information to correct each of the violative message(s), and be free of promotional claims and presentations..

Also interested in other HR templates? Browse through our database and have instant access to hundreds of free and premium HR documents, HR forms, HR agreements, etc


HAFTUNGSAUSSCHLUSS
Nichts auf dieser Website gilt als Rechtsberatung und kein Mandatsverhältnis wird hergestellt.


Wenn Sie Fragen oder Anmerkungen haben, können Sie sie gerne unten veröffentlichen.


default user img

Verwandte Vorlagen


Neueste Vorlagen


Neueste Themen


Mehr Themen